Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 8NIH 4INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Diabetes Mellitus 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Neoplasms 1

Interventions

Paclitaxel 337pembrolizumab 332Carboplatin 330Cisplatin 277Gemcitabine 264Docetaxel 251Bevacizumab 239Nivolumab 230Pemetrexed 211Rituximab 183Dexamethasone 183Cyclophosphamide 169Capecitabine 169Trastuzumab 149Fluorouracil 147Ipilimumab 121atezolizumab 118Prednisone 117Erlotinib Hydrochloride 116Oxaliplatin 109Cetuximab 104Sunitinib 101Leucovorin 97Doxorubicin 97Lenalidomide 93Irinotecan 89130-nm albumin-bound paclitaxel 84durvalumab 77Bortezomib 77Azacitidine 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Pioglitazone × Clear all
NCT01637935 2018-03-07

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Takeda

Completed
193,099 enrolled 15 charts
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT02958956 2018-03-07

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Takeda

Completed
236,507 enrolled 13 charts

Diabetes Mellitus, Neoplasms

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed
67 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡